Newsclip®: [Health] Breast cancer drug rejected for NHS despite doubling destruction of tumours | Daily Mail Online

"Women who took Perjeta were 40 per cent more likely to be disease-free after three years but the drug will not be available on the NHS following the decision by NICE.", www.dailymail.co.uk


0 comments | 1 clip

advertisement

 

Last clipped by


Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.
Feedback



Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.